The prevalence of renal disease in MS ranged from 0.74% to 2.49%.[21] The most common type of renal disease reported is glomerulonephritis,[11–14,16,17] which is induced by IFN-β therapy. Here, IFNB1 is linked to myeloid sarcoma.